KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,397,083 | +18.2% | 2,958,957 | -4.2% | 0.00% | 0.0% |
| Q2 2023 | $43,467,944 | +23.9% | 3,087,212 | -5.3% | 0.00% | 0.0% |
| Q1 2023 | $35,084,303 | -27.4% | 3,260,623 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $48,338,828 | +22.3% | 3,226,891 | +4.8% | 0.00% | 0.0% |
| Q3 2022 | $39,536,000 | +39.3% | 3,079,192 | +5.2% | 0.00% | 0.0% |
| Q2 2022 | $28,372,000 | -5.1% | 2,927,981 | -2.6% | 0.00% | 0.0% |
| Q1 2022 | $29,886,000 | -12.2% | 3,006,650 | +4.0% | 0.00% | 0.0% |
| Q4 2021 | $34,022,000 | +12.2% | 2,890,708 | +8.6% | 0.00% | 0.0% |
| Q3 2021 | $30,328,000 | -18.3% | 2,662,626 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $37,114,000 | -28.5% | 2,664,323 | -4.9% | 0.00% | 0.0% |
| Q1 2021 | $51,884,000 | +15.8% | 2,803,047 | +10.5% | 0.00% | 0.0% |
| Q4 2020 | $44,819,000 | +23.3% | 2,536,421 | +6.9% | 0.00% | 0.0% |
| Q3 2020 | $36,344,000 | -16.8% | 2,372,284 | +38.3% | 0.00% | -50.0% |
| Q2 2020 | $43,697,000 | +135.1% | 1,714,942 | +42.9% | 0.00% | +100.0% |
| Q1 2020 | $18,584,000 | +39.9% | 1,200,511 | -0.1% | 0.00% | – |
| Q4 2019 | $13,288,000 | +33.9% | 1,201,453 | +3.0% | 0.00% | – |
| Q3 2019 | $9,927,000 | -41.0% | 1,166,511 | -6.2% | 0.00% | -100.0% |
| Q2 2019 | $16,835,000 | -25.2% | 1,243,362 | -0.2% | 0.00% | 0.0% |
| Q1 2019 | $22,507,000 | -11.8% | 1,246,224 | +37.2% | 0.00% | 0.0% |
| Q4 2018 | $25,514,000 | +80.0% | 908,273 | +63.4% | 0.00% | 0.0% |
| Q3 2018 | $14,178,000 | +444.9% | 555,991 | +270.7% | 0.00% | – |
| Q2 2018 | $2,602,000 | – | 150,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |